Takeda Pharmaceutical Co Ltd

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001395064
Type: FundHoldings: 11Value: $14.4MLatest: 2025Q1

TAKEDA PHARMACEUTICAL CO LTD is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 11 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
11
Total Value
14400016
Accession Number
0001395064-25-000055
Form Type
13F-HR
Manager Name
Takeda-Pharmaceutical-Co
Data Enrichment
100% identified
11 identified0 unidentified

Holdings

11 positions • $14.4M total value
Manager:
Search and click to pin securities to the top
HilleVax, Inc.
Shares:6.7M
Value:$9.8M
% of Portfolio:67.7% ($9.8M/$14.4M)
Xilio Therapeutics, Inc.
Shares:1.5M
Value:$1.1M
% of Portfolio:7.4% ($1.1M/$14.4M)
Equillium, Inc.
Shares:1.8M
Value:$711.7K
% of Portfolio:4.9% ($711.7K/$14.4M)
American Well Corp
Shares:77.7K
Value:$612.5K
% of Portfolio:4.3% ($612.5K/$14.4M)
Ovid Therapeutics Inc.
Shares:1.8M
Value:$555.8K
% of Portfolio:3.9% ($555.8K/$14.4M)
Shattuck Labs, Inc.
Shares:515.6K
Value:$489.8K
% of Portfolio:3.4% ($489.8K/$14.4M)
Lyell Immunopharma, Inc.
Shares:823.3K
Value:$442.9K
% of Portfolio:3.1% ($442.9K/$14.4M)
Turnstone Biologics Corp.
Shares:895.8K
Value:$367.3K
% of Portfolio:2.6% ($367.3K/$14.4M)
Rani Therapeutics Holdings, Inc.
Shares:203.2K
Value:$256.0K
% of Portfolio:1.8% ($256.0K/$14.4M)
Third Harmonic Bio, Inc.
Shares:36.8K
Value:$127.8K
% of Portfolio:0.9% ($127.8K/$14.4M)
STANDARD BIOTOOLS INC.
Shares:16.5K
Value:$17.8K
% of Portfolio:0.1% ($17.8K/$14.4M)